As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a ...

The company’s fifty day simple moving average is $5.59 and its two-hundred day simple moving average is $5.55. ESSA Pharma has a 52 week low of $1.40 and a 52 week high of $11.67. The stock has a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Phase 2 trial initiation in patients with sleep /wake disorders results in milestone payment of US$3.5 million to NxeraTokyo, Japan and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Drugmaker Mayne Pharma Group, which has lost 59 per cent of its share market value over the past five years, is giving some thought to life away from the ASX boards. Pubs baron Bruce Mathieson at ...

SOHO stock opened at $1.28 on Monday. The firm has a 50-day moving average price of $1.23 and a 200-day moving average price of $1.26. Sotherly Hotels has a 12 month low of $1.05 and a 12 month ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

In the life sciences industry in particular, leading pharma companies are already deploying this technology across their own operations to spur productivity and efficiency for mundane, time ...

Why President-elect Donald Trump’s return could disrupt pharma. From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma industry.